Rabies in the SAARC region: An epidemiological study of disease burden and challenges-Reference-Cited by-同舟云学术

Rabies in the SAARC region: An epidemiological study of disease burden and challenges

Published:2023-06-05 Issue:4 Volume:53 Page:437-440
ISSN:0049-4755
Container-title:Tropical Doctor
language:en
Short-container-title:Trop Doct

Author:

Mubashar Bareea¹,Iqbal Sidra²,Noor Amna²,Sarfraz Azza³,Sarfraz Zouina⁴^ORCID

Affiliation:

1. Graduate Medical Researcher, Department of Medical Education, King Edward Medical University, Lahore, Pakistan

2. Graduate Medical Researcher, Department of Research, University Medical and Dental College, Faisalabad, Pakistan

3. Clinical Research Associate, Department of Pediatrics and Child Health, The Aga Khan University, Karachi, Pakistan

4. Graduate Medical Researcher, Department of Research and Publications, Fatima Jinnah Medical University, Lahore, Pakistan

Abstract

Our original study explored trends in rabies-related cases in the South Asian Association for Regional Cooperation region from 2017 to 2021. We analyzed population-level data from Global Health Observatory, World Animal Health Information Database and media reports using Microsoft Excel v.2016. Rabies prevalence varied with India experiencing the highest increase, while Bhutan reported a significant decrease. In contrast, Nepal and Pakistan observed fluctuations, emphasizing the need for ongoing intervention.

Publisher

SAGE Publications

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health

Link

http://journals.sagepub.com/doi/pdf/10.1177/00494755231179765

Reference12 articles.

1. Human Rabies in the WHO Southeast Asia Region: Forward Steps for Elimination

2. Rabies in South Asia: Fighting for Elimination

3. Epidemiological study of human rabies cases in Bangladesh through verbal autopsy

4. Rabies control in South Asia requires a One Health approach

5. World Health Organization. Rabies, https://www.who.int/southeastasia/health-topics/rabies (2022, accessed 10 May 2023).